Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 113
Filter
1.
AJNR Am J Neuroradiol ; 31(7): 1350-2, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20190206

ABSTRACT

Contrary to the common belief that age-related WMLs (also known as leukoaraiosis) are a progressive condition, a case of partial reversal of WMLs shortly after carotid artery stenting is described. A 75-year-old man presented with frequent TIAs, which were attributed to right ICA stenosis. He subsequently underwent successful carotid artery stenting. Follow-up MR imaging a week after the procedure showed improvement of WMLs in the right cerebral hemisphere. Pixel-by-pixel image analysis showed that the reversed WMLs tended to have higher lambda1 and lower signal intensity on b = 0 images compared with nonreversed lesions, but by only approximately 10%.


Subject(s)
Carotid Artery Diseases/pathology , Carotid Artery Diseases/therapy , Leukoencephalopathies/pathology , Leukoencephalopathies/therapy , Stents , Aged , Cerebral Cortex/pathology , Disease Progression , Humans , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male
2.
Phys Rev Lett ; 100(22): 221803, 2008 Jun 06.
Article in English | MEDLINE | ID: mdl-18643415

ABSTRACT

The KamLAND experiment has determined a precise value for the neutrino oscillation parameter Deltam21(2) and stringent constraints on theta12. The exposure to nuclear reactor antineutrinos is increased almost fourfold over previous results to 2.44 x 10(32) proton yr due to longer livetime and an enlarged fiducial volume. An undistorted reactor nu[over]e energy spectrum is now rejected at >5sigma. Analysis of the reactor spectrum above the inverse beta decay energy threshold, and including geoneutrinos, gives a best fit at Deltam21(2)=7.58(-0.13)(+0.14)(stat) -0.15+0.15(syst) x 10(-5) eV2 and tan2theta12=0.56(-0.07)+0.10(stat) -0.06+0.10(syst). Local Deltachi2 minima at higher and lower Deltam21(2) are disfavored at >4sigma. Combining with solar neutrino data, we obtain Deltam21(2)=7.59(-0.21)+0.21 x 10(-5) eV2 and tan2theta12=0.47(-0.05)+0.06.

3.
Phys Rev Lett ; 96(10): 101802, 2006 Mar 17.
Article in English | MEDLINE | ID: mdl-16605724

ABSTRACT

The Kamioka Liquid scintillator Anti-Neutrino Detector is used in a search for single neutron or two-neutron intranuclear disappearance that would produce holes in the -shell energy level of (12)C nuclei. Such holes could be created as a result of nucleon decay into invisible modes (inv), e.g., n--> 3v or nn--> 2v. The deexcitation of the corresponding daughter nucleus results in a sequence of space and time-correlated events observable in the liquid scintillator detector. We report on new limits for one- and two-neutron disappearance: tau(n--> inv) > 5.8 x 10(29) years and tau (nn--> inv) > 1.4 x 10(30) years at 90% C.L. These results represent an improvement of factors of approximately 3 and >10(4) and over previous experiments.

4.
Neurology ; 65(4): 629-32, 2005 Aug 23.
Article in English | MEDLINE | ID: mdl-16116133

ABSTRACT

Presented is the new kindred with autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 (16q-ADCA type III) associated with progressive hearing loss. By haplotype analysis, the critical interval was slightly narrowed to three megabase regions between GATA01 and D16S3095. Neuropathologic study of 16q-ADCA type III demonstrated characteristic shrinkage of Purkinje cell bodies surrounded by synaptophysin-immunoreactive amorphous material containing calbindin- and ubiquitin-positive granules.


Subject(s)
Cerebellar Ataxia/genetics , Chromosome Disorders/genetics , Chromosomes, Human, Pair 16/genetics , Gait Ataxia/genetics , Genes, Dominant , Hearing Loss/genetics , Adolescent , Adult , Age of Onset , Aged , Aged, 80 and over , Cerebellar Ataxia/pathology , Child , Chromosome Disorders/pathology , Chromosome Disorders/physiopathology , Chromosome Mapping , Cochlea/physiopathology , DNA Mutational Analysis , Disease Progression , Female , Gait Ataxia/pathology , Gait Ataxia/physiopathology , Genetic Markers/genetics , Genetic Predisposition to Disease/genetics , Genetic Testing , Hearing Loss/physiopathology , Humans , Japan , Male , Middle Aged , Pedigree , Purkinje Cells/metabolism , Purkinje Cells/pathology
5.
Nature ; 436(7050): 499-503, 2005 Jul 28.
Article in English | MEDLINE | ID: mdl-16049478

ABSTRACT

The detection of electron antineutrinos produced by natural radioactivity in the Earth could yield important geophysical information. The Kamioka liquid scintillator antineutrino detector (KamLAND) has the sensitivity to detect electron antineutrinos produced by the decay of 238U and 232Th within the Earth. Earth composition models suggest that the radiogenic power from these isotope decays is 16 TW, approximately half of the total measured heat dissipation rate from the Earth. Here we present results from a search for geoneutrinos with KamLAND. Assuming a Th/U mass concentration ratio of 3.9, the 90 per cent confidence interval for the total number of geoneutrinos detected is 4.5 to 54.2. This result is consistent with the central value of 19 predicted by geophysical models. Although our present data have limited statistical power, they nevertheless provide by direct means an upper limit (60 TW) for the radiogenic power of U and Th in the Earth, a quantity that is currently poorly constrained.

7.
Phys Rev Lett ; 94(8): 081801, 2005 Mar 04.
Article in English | MEDLINE | ID: mdl-15783875

ABSTRACT

We present results of a study of neutrino oscillation based on a 766 ton/year exposure of KamLAND to reactor antineutrinos. We observe 258 nu (e) candidate events with energies above 3.4 MeV compared to 365.2+/-23.7 events expected in the absence of neutrino oscillation. Accounting for 17.8+/-7.3 expected background events, the statistical significance for reactor nu (e) disappearance is 99.998%. The observed energy spectrum disagrees with the expected spectral shape in the absence of neutrino oscillation at 99.6% significance and prefers the distortion expected from nu (e) oscillation effects. A two-neutrino oscillation analysis of the KamLAND data gives Deltam(2)=7.9(+0.6)(-0.5)x10(-5) eV(2). A global analysis of data from KamLAND and solar-neutrino experiments yields Deltam(2)=7.9(+0.6)(-0.5)x10(-5) eV(2) and tan((2)theta=0.40(+0.10)(-0.07), the most precise determination to date.

8.
Clin Nephrol ; 63(2): 68-73, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15730047

ABSTRACT

BACKGROUND AND AIM: Corticosteroid therapy is an effective way of treatment for many renal diseases, however, it is sometimes associated with infections. Our aim is to identify useful predictive markers of infection during steroid therapy. METHODS: We examined 121 patients (M/F = 71/50, mean age 43.8, range 15 - 82 years) who were treated with corticosteroids (IgA nephropathy in 51, minimal-change disease in 17, membranous nephropathy in 16 rapidly progressive glomerulonephritis (RPGN) in 13, lupus nephritis in 12 and other disorders in 12). Karnofsky's performance score (KPS) was employed to assess the physical functional status at the time of diagnosis. Infections were defined as conditions that required more than 1-week care, and those that caused the patient's death. RESULTS: Nineteen patients (15.7%) had infections during treatment. A logistic multivariate analysis showed significant correlations between infection and the use of immunosuppressive agents (relative risk RR = 7.7, p = 0.0265), ages of 52.9 years or more (RR = 13.5, p = 0.0026), initial number of lymphocytes (Lym) less than 1.250/microl (RR = 14.2, p = 0.0011), and KPS less than 77.4 (RR = 12.1, p = 0.0020). All correlations with infection were independent of all the other variables listed above. CONCLUSION: KPS, along with age, Lym and the use of immunosuppressive agents, are useful for the prediction of infectious complications during steroid therapy.


Subject(s)
Activities of Daily Living , Glucocorticoids/adverse effects , Health Status , Karnofsky Performance Status , Kidney Diseases/drug therapy , Opportunistic Infections/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Drug Therapy, Combination , Female , Follow-Up Studies , Glucocorticoids/administration & dosage , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/adverse effects , Male , Middle Aged , Sensitivity and Specificity
10.
Clin Nephrol ; 61(1): 68-73, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14964461

ABSTRACT

A 48-year-old male was admitted to our hospital because of increasing knee pain and thigh muscle weakness. He had been undergoing hemodialysis for 15 years. His serum intact PTH value was 1,600 pg/ml with elevated ALP (387 IU/l) and osteocalcin (400 ng/ml). Ultrasound (US) examination disclosed 2 enlarged parathyroid glands. Because of poor cardiac function, an US-guided acetic acid injection into the enlarged parathyroids (percutaneous acetic acid injection therapy; PAIT) was performed. Soon after the PAIT, his arthralgia disappeared. Serum PTH fell to 220 pg/ml with the regression of bone marker 1 year following the PAIT. The size of his parathyroid glands dramatically regressed and 1 of the enlarged glands finally disappeared. Repeated bone biopsies following double tetracycline labeling showed a significant improvement from osteitis fibrosa to the mild lesion. This is the first known case report of severe secondary hyperparathyroidism whose PTH and high turnover bone was successfully managed by the direct injection of acetic acid into the parathyroid glands. As long as we pay attention to avoiding recurrent nerve palsy induced by acetic acid, US-guided PAIT may be an alternative to percutaneous ethanol injection therapy (PEIT) or surgical parathyroidectomy (PTx).


Subject(s)
Acetic Acid/administration & dosage , Bone and Bones/drug effects , Bone and Bones/metabolism , Hyperparathyroidism, Secondary/drug therapy , Hyperparathyroidism, Secondary/metabolism , Humans , Injections, Intralesional , Male , Middle Aged , Parathyroid Glands
11.
Phys Rev Lett ; 90(2): 021802, 2003 Jan 17.
Article in English | MEDLINE | ID: mdl-12570536

ABSTRACT

KamLAND has measured the flux of nu;(e)'s from distant nuclear reactors. We find fewer nu;(e) events than expected from standard assumptions about nu;(e) propagation at the 99.95% C.L. In a 162 ton.yr exposure the ratio of the observed inverse beta-decay events to the expected number without nu;(e) disappearance is 0.611+/-0.085(stat)+/-0.041(syst) for nu;(e) energies >3.4 MeV. In the context of two-flavor neutrino oscillations with CPT invariance, all solutions to the solar neutrino problem except for the "large mixing angle" region are excluded.

12.
Neurol Med Chir (Tokyo) ; 41(8): 393-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11561350

ABSTRACT

Four patients presented with intracranial hemorrhage mainly consisting of acute subdural hematoma (ASDH), who had all undergone aneurysm clipping 2-20 years earlier. Whether the clips had slipped or new trauma had caused the bleeding was difficult to determine, since the initial computed tomography showed that the subarachnoid hemorrhage or the intracerebral hematoma developed near the clips. Angiography in three patients showed that the clips had not slipped off. Three of four ASDHs appeared in the same side as the craniotomy used for the previous aneurysm surgery. Anti-platelet agents and ventriculoperitoneal shunting had been previously used in two patients with no causal signs of trauma. The outcomes were poor in three patients and one patient died. Weakening of the extra- or intracranial structure after aneurysm surgery might have been involved together with the postoperative anti-platelet agent and shunt treatment in the etiology of the present ASDH.


Subject(s)
Hematoma, Subdural, Acute/surgery , Intracranial Aneurysm/surgery , Postoperative Complications/surgery , Aged , Aged, 80 and over , Cerebral Angiography , Female , Follow-Up Studies , Hematoma, Subdural, Acute/diagnostic imaging , Humans , Intracranial Aneurysm/diagnostic imaging , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Reoperation , Risk Factors , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/surgery , Tomography, X-Ray Computed
13.
Neurology ; 56(12): 1753-6, 2001 Jun 26.
Article in English | MEDLINE | ID: mdl-11425948

ABSTRACT

Aggregations of the alpha1A-calcium channel protein have been previously demonstrated in spinocerebellar ataxia type 6 (SCA6). Here the authors show that small aggregates, labeled by a monoclonal antibody 1C2 that preferentially detects expanded polyglutamine larger than that in SCA6 mutation, are present mainly in the cytoplasm but also in the nucleus of Purkinje cells. Although the length of expansion is small in SCA6, the current finding might indicate that SCA6 conforms to the pathogenic mechanism(s) in other polyglutamine diseases.


Subject(s)
Cytoplasm/metabolism , Peptides/analysis , Purkinje Cells/metabolism , Spinocerebellar Ataxias/metabolism , Brain/metabolism , Humans , Peptides/genetics , Spinocerebellar Ataxias/genetics , Trinucleotide Repeats/genetics
14.
J Neurosurg ; 93(1): 19-25, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10883900

ABSTRACT

OBJECT: Although the spontaneous occurrence of an unruptured vertebral artery (VA) dissection has increasingly been recognized as a relatively common cause of stroke, and the clinical aspects of this lesion have gradually been determined, its natural course remains obscure. The main goal of this study was to clarify the management protocol for this condition by examining serial angiographic changes in patients with unruptured VA dissections. METHODS: Seventeen patients with unruptured VA dissections, including 13 men and four women, were clinically and angiographically examined between 1993 and 1998. All patients were observed using serial angiography studies. The initial angiography examinations most frequently revealed stenotic lesions (appearance of a pearl-and-string sign or string sign) in eight (47.1%) of 17 cases. In 15 cases (88.2%), changes in the lesions were evident on follow-up angiography studies. Stenotic lesions resulted in occlusion in four cases, normalization in three, and subsequent formation of an aneurysm in one case, which was treated successfully by proximal occlusion of the affected vessel performed using a detachable balloon. Occluded lesions, which were initially observed in three patients, recanalized in two patients and remained unchanged in one patient. Fusiform dilation alone was demonstrated in three patients during the initial angiography session; these lesions became normalized or were unchanged on follow-up studies. Saccular aneurysms were observed in two patients. In one of these cases, proximal ligation of the parent artery was successfully performed because of subsequent aneurysm enlargement. A double lumen, which appeared in one patient with an extradural VA dissection, became occluded. Magnetic resonance T2-weighted imaging studies revealed infarction corresponding to the posterior circulation in seven cases. During long-term observation in this series, good or excellent recovery was obtained in 14 (87.5%) of 16 patients, and moderate or severe disability in two (12.5%); one patient was lost to follow up after the second angiography study. CONCLUSIONS: A follow-up angiography study must be performed during the early stage (within approximately 3 weeks after onset of symptoms) to confirm the formation or enlargement of an aneurysm, because such conditions may be amenable to surgical treatment. Unruptured VA dissection could otherwise be treated and followed conservatively. Although the majority of dissected lesions seem likely to stabilize within a few months, as evidenced on angiography, in some cases a longer observation period is required.


Subject(s)
Aortic Dissection/diagnostic imaging , Cerebral Angiography , Intracranial Aneurysm/diagnostic imaging , Vertebral Artery/diagnostic imaging , Adult , Aged , Aortic Dissection/therapy , Embolization, Therapeutic , Female , Follow-Up Studies , Humans , Intracranial Aneurysm/therapy , Male , Middle Aged , Neurologic Examination , Retrospective Studies , Treatment Outcome
15.
J Neurochem ; 73(5): 2084-92, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10537068

ABSTRACT

Midkine (MK) is a new member of the heparin-binding neurotrophic factor family. MK plays important roles in development and carcinogenesis and has several important biological effects, including promotion of neurite extension and neuronal survival. However, the mechanism by which MK exerts its neurotrophic actions on neurons has not been elucidated to date. We have established an apoptosis induction system by serum deprivation in primary neuronal cultures isolated from mouse cerebral cortices. Neuronal apoptosis induced by serum deprivation was accompanied by the activation of caspase-3. MK, when added into the culture medium, inhibited the induction of apoptosis and activation of caspase-3 in a dose-dependent manner. Extracellular signal-regulated kinase (ERK) and Akt were not activated by serum deprivation, whereas ERK and Akt were rapidly activated by addition of MK. In addition, the trophic actions of MK of suppressing apoptosis and suppressing the activation of caspase-3 were abolished by concomitant treatment with PD98059, a specific inhibitor of mitogen-activated protein kinase kinase, and with wort-mannin or LY294002, specific inhibitors of phosphatidyl-inositol 3-kinase (PI 3-kinase). These PI 3-kinase inhibitors also inhibited the activation of ERK in response to MK, demonstrating a link between ERK and the caspase-3 pathway that is modulated by the PI 3-kinase activation. These results indicate that the ERK cascade plays a central role in MK-mediated neuronal survival via inhibition of caspase-3 activation.


Subject(s)
Apoptosis/drug effects , Carrier Proteins/pharmacology , Caspases/pharmacology , Cytokines , Mitogen-Activated Protein Kinases/metabolism , Neurons/enzymology , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins , Androstadienes/pharmacology , Animals , Caspase 3 , Cells, Cultured , Cerebral Cortex , Culture Media, Serum-Free , Embryo, Mammalian , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , In Situ Nick-End Labeling , Mice , Midkine , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Phosphoinositide-3 Kinase Inhibitors , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins c-akt , Recombinant Proteins/pharmacology , Wortmannin
16.
Nihon Jinzo Gakkai Shi ; 41(2): 89-94, 1999 Apr.
Article in Japanese | MEDLINE | ID: mdl-10361425

ABSTRACT

We report the case of a 21-year-old man who had been developing acute renal failure with Methicillin-resistant Staphylococcus aureus (MRSA) colitis and sepsis. He was admitted for consciousness disturbance, nausea, vomiting, and diarrhea. Oliguria was also observed and his serum creatinine level was elevated to 10 mg/dl. Urinary protein was positive and an abundance of hyaline cast were seen in urinary sedimentation. Diarrhea and pyrexia were prolonged and serum C-reactive proteins were elevated, but lymphocyte and leukocyte counts temporarily decreased from the 3rd to the 6th hospital day and remained low until normalizing after the 14th day. His clinical symptoms improved with hemodialysis (HD) and effective antibiotic therapies. An MRSA strain producing toxic shock syndrome toxin-1 (TSST-1), a super antigen which specifically stimulates human V beta 2-positive T cells, was separated from his feces and blood. To ascertain the cause of his renal dysfunction, a renal biopsy was performed on the 8th day. His renal histology revealed acute interstitial nephritis with severe inflammatory cell infiltration around the medullary areas without glomerular changes. Most of the infiltrated cells were small monocytes, and lymphoid cells were rich in the interstitium. With immunohistochemical staining, over 70% of T-cells were V beta 2-positive. TSST-1-producing MRSA was detected in his blood specimen. Furthermore, V beta 2-positive T cells were accumulated in the renal intersititium, and transient lymphocytopenia was observed. These data suggested the following possible pathogenesis for interstitial nephritis: TSST-1 acts as a super antigen in the renal interstitium where major histocompatibility complex (MHC) is class-2-positive, thereby resulting in interstitial nephritis with T cell migration.


Subject(s)
Acute Kidney Injury/etiology , Bacterial Toxins , Enterotoxins/adverse effects , Methicillin Resistance , Nephritis, Interstitial/etiology , Staphylococcus aureus/immunology , Superantigens/adverse effects , Adult , Colitis/complications , Colitis/microbiology , Humans , Male , Sepsis/complications , Sepsis/microbiology , Staphylococcal Infections
17.
Hypertension ; 33(1 Pt 2): 201-6, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9931105

ABSTRACT

-PYK2, a recently identified Ca2+-sensitive tyrosine kinase, has been implicated in extracellular signal-regulated kinase (ERK) activation via several G protein-coupled receptors. We have reported that angiotensin II (Ang II) induces Ca2+-dependent transactivation of the epidermal growth factor receptor (EGFR) which serves as a scaffold for preactivated c-Src and downstream adaptors (Shc/Grb2), leading to ERK activation in cultured rat vascular smooth muscle cells (VSMC). Herein we demonstrate the involvement of PYK2 in this cascade. Ang II rapidly induced tyrosine phosphorylation of PYK2, whose effect was completely inhibited by an AT1 receptor antagonist and an intracellular Ca2+ chelator. A Ca2+ ionophore also induced PYK2 tyrosine phosphorylation to a level comparable with that by Ang II, whereas phorbol ester-induced phosphorylation was less than that by Ang II. Moreover, PYK2 formed a complex coprecipitable with catalytically active c-Src after Ang II stimulation. Although a selective EGFR kinase inhibitor completely abolished Ang II-induced recruitment of Grb2 to EGFR and markedly attenuated Ang II-induced ERK activation, it had no effect on Ang II-induced PYK2 tyrosine phosphorylation or its association with c-Src and Grb2. These data suggest that the AT1 receptor uses Ca2+-dependent PYK2 to activate c-Src, thereby leading to EGFR transactivation, which preponderantly recruits Grb2 in rat VSMC.


Subject(s)
Angiotensin II/physiology , Aorta, Thoracic/physiology , ErbB Receptors/physiology , Muscle, Smooth, Vascular/physiology , Protein-Tyrosine Kinases/metabolism , Signal Transduction/physiology , Angiotensin II/pharmacology , Animals , Aorta, Thoracic/drug effects , Calcium/metabolism , Cells, Cultured , Chelating Agents/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Epidermal Growth Factor/pharmacology , ErbB Receptors/drug effects , Focal Adhesion Kinase 2 , Humans , Models, Biological , Muscle, Smooth, Vascular/drug effects , Phosphorylation , Rats , Rats, Sprague-Dawley , Receptors, Angiotensin/drug effects , Receptors, Angiotensin/physiology , Recombinant Proteins/pharmacology , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology
18.
Science ; 283(5402): 655-61, 1999 Jan 29.
Article in English | MEDLINE | ID: mdl-9924018

ABSTRACT

The Ras-dependent activation of mitogen-activated protein (MAP) kinase pathways by many receptors coupled to heterotrimeric guanine nucleotide binding proteins (G proteins) requires the activation of Src family tyrosine kinases. Stimulation of beta2 adrenergic receptors resulted in the assembly of a protein complex containing activated c-Src and the receptor. Src recruitment was mediated by beta-arrestin, which functions as an adapter protein, binding both c-Src and the agonist-occupied receptor. beta-Arrestin 1 mutants, impaired either in c-Src binding or in the ability to target receptors to clathrin-coated pits, acted as dominant negative inhibitors of beta2 adrenergic receptor-mediated activation of the MAP kinases Erk1 and Erk2. These data suggest that beta-arrestin binding, which terminates receptor-G protein coupling, also initiates a second wave of signal transduction in which the "desensitized" receptor functions as a critical structural component of a mitogenic signaling complex.


Subject(s)
Arrestins/metabolism , Mitogen-Activated Protein Kinases , Proto-Oncogene Proteins pp60(c-src)/metabolism , Receptors, Adrenergic, beta-2/metabolism , Signal Transduction , Adrenergic beta-Agonists/metabolism , Adrenergic beta-Agonists/pharmacology , Animals , Arrestins/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Line , Cell Membrane/metabolism , Enzyme Activation , GTP-Binding Proteins/metabolism , Humans , Isoproterenol/metabolism , Isoproterenol/pharmacology , Mitogen-Activated Protein Kinase 1 , Mitogen-Activated Protein Kinase 3 , Models, Biological , Phosphorylation , Point Mutation , Precipitin Tests , Receptor Cross-Talk , Receptors, Cell Surface/metabolism , Transfection , beta-Arrestin 1 , beta-Arrestins , src Homology Domains
19.
J Med Dent Sci ; 46(1): 45-51, 1999 Mar.
Article in English | MEDLINE | ID: mdl-12160213

ABSTRACT

Midkine (MK) is a new member of the family of heparin-binding neurotrophic factors. MK has several important biological effects and plays an important role in the development and survival of neurons. The mechanism by which MK exerts its neurotrophic actions, however has not been sufficiently clarified. To understand the intracellular pathway activated by MK, we established an apoptosis-induction system with the neuronal cell line PC12 and studied the involvement of the mitogen-activated protein kinase (MAPK) cascade in neuroprotective actions of MK. We demonstrate here that MK rescued PC12 cells from apoptosis induced by serum deprivation in a dose-dependent manner. MK also activated extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2), which are well known as signal transducer acting downstream several receptors. PD98059, an inhibitor of MAPK kinase (MAPKK), inhibited ERK activation and also prevented the trophic effect of MK. These results indicate that MK exerts its neuroprotective actions mainly via ERK activation.


Subject(s)
Apoptosis/drug effects , Carrier Proteins/pharmacology , Carrier Proteins/physiology , Cytokines , MAP Kinase Signaling System/drug effects , Mitogen-Activated Protein Kinases/biosynthesis , Nerve Growth Factors/physiology , Neuroprotective Agents/pharmacology , Animals , Blotting, Western , Coloring Agents , Culture Media, Serum-Free , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , In Situ Nick-End Labeling , Midkine , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Nerve Growth Factors/pharmacology , PC12 Cells , Rats , Recombinant Proteins/pharmacology , Tetrazolium Salts , Thiazoles
20.
J Neurosci Res ; 54(5): 604-12, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9843151

ABSTRACT

MS-818 (2-piperadino-6-methyl-5-oxo-5, 6-dihydro (7H) pyrrolo [2,3-d]pyrimidine maleate), a newly synthesized heterocyclic pyrimidine derivative, promotes neurite outgrowth in neuronal cell lines. The survival-promoting effect of MS-818 on cultured neurons isolated from mouse cortices was examined. MS-818 promoted neuronal survival by inhibiting apoptosis in a dose-dependent manner. MS-818 treatment also activated mitogen-activated protein kinase (MAPK) of the extracellular signal regulation kinase 2, as demonstrated by Western blot analysis. The MAPK activation level in the cultures treated with MS-818 was almost equivalent to that in cultures treated with nerve growth factor but was less than that in cultures treated with epidermal growth factor and basic fibroblast growth factor (bFGF). MAPK was activated within 3 min after the addition of MS-818, and its activity level returned to baseline within 120 min. Its activation was protein kinase C independent. We further investigated the effect of concurrent treatment with MS-818 and bFGF on neuronal survival. MS-818 enhanced the neuronal survival-promoting effect of bFGF in shifting the half-maximally effective dose from 2.1 ng/ml to 0.036 ng/ml in the sigmoidal dose effect of bFGF and permitted nearly maximum MAPK activation. The enhancement by MS-818 of the neuronal survival-promoting effect of bFGF was accompanied by sustained activation of MAPK to a degree that far exceeded, in magnitude and duration, the cooperative effect of MS-818 and bFGF. These results indicate that MS-818 promotes neuronal survival and enhances the neurotrophic actions of bFGF through stimulation of synchronous signals that may elevate MAPK levels within neurons.


Subject(s)
Fibroblast Growth Factor 2/pharmacology , Mitogen-Activated Protein Kinases , Neurites/drug effects , Neuroprotective Agents/pharmacology , Pyrimidines/pharmacology , Signal Transduction/drug effects , Animals , Apoptosis/drug effects , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cells, Cultured , Cerebral Cortex/cytology , Depression, Chemical , Drug Synergism , Enzyme Activation/drug effects , Mice , Mitogen-Activated Protein Kinase 1 , Mitogen-Activated Protein Kinase 3 , Molecular Structure , Nerve Tissue Proteins/metabolism , Neurites/ultrastructure , Neuroprotective Agents/chemistry , Protein Kinase C/analysis , Pyrimidines/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...